A detailed history of Cannon Financial Strategists, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 3,916 shares of MRK stock, worth $396,181. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,916
Previous 3,705 5.7%
Holding current value
$396,181
Previous $404 Million 10.1%
% of portfolio
0.08%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$111.15 - $128.97 $23,452 - $27,212
211 Added 5.7%
3,916 $445 Million
Q2 2024

Sep 10, 2024

BUY
$123.8 - $132.96 $505,723 - $543,141
4,085 New
4,085 $506 Million
Q4 2023

Oct 18, 2024

SELL
$100.18 - $109.02 $38,068 - $41,427
-380 Reduced 9.3%
3,705 $404 Million
Q3 2023

Oct 18, 2024

SELL
$102.95 - $114.33 $4,220 - $4,687
-41 Reduced 1.1%
3,692 $380 Million
Q3 2023

Oct 02, 2024

SELL
$102.95 - $114.33 $364,031 - $404,270
-3,536 Closed
0 $0
Q1 2023

Oct 02, 2024

BUY
$102.94 - $114.86 $363,995 - $406,144
3,536 New
3,536 $376 Million
Q4 2022

Oct 18, 2024

BUY
$87.44 - $112.11 $2,448 - $3,139
28 Added 0.76%
3,733 $414 Million
Q4 2022

Oct 02, 2024

SELL
$87.44 - $112.11 $786,085 - $1.01 Million
-8,990 Closed
0 $0
Q3 2022

Oct 02, 2024

BUY
$84.53 - $94.96 $759,924 - $853,690
8,990 New
8,990 $689 Million
Q2 2022

Oct 18, 2024

BUY
$83.49 - $94.64 $7,931 - $8,990
95 Added 2.64%
3,691 $337 Million
Q1 2022

Oct 18, 2024

BUY
$73.51 - $82.4 $1,617 - $1,812
22 Added 0.62%
3,596 $295 Million
Q4 2021

Oct 18, 2024

SELL
$72.28 - $90.54 $9,468 - $11,860
-131 Reduced 3.54%
3,574 $274 Million
Q3 2021

Oct 02, 2024

SELL
$71.68 - $78.83 $17.1 Million - $18.8 Million
-238,883 Closed
0 $0
Q2 2021

Oct 02, 2024

BUY
$70.31 - $77.77 $16.5 Million - $18.3 Million
234,798 Added 5747.81%
238,883 $12.3 Billion
Q1 2021

Oct 02, 2024

BUY
$68.86 - $81.11 $1,583 - $1,865
23 Added 0.65%
3,574 $276 Million
Q4 2020

Oct 18, 2024

SELL
$71.77 - $79.65 $9,401 - $10,434
-131 Reduced 3.54%
3,574 $292 Million
Q4 2020

Oct 02, 2024

SELL
$71.77 - $79.65 $1,650 - $1,831
-23 Reduced 0.64%
3,551 $1.33 Billion
Q3 2020

Oct 02, 2024

SELL
$73.18 - $82.95 $37,394 - $42,387
-511 Reduced 12.51%
3,574 $296 Million
Q2 2020

Oct 18, 2024

SELL
$70.42 - $80.13 $6,056 - $6,891
-86 Reduced 2.32%
3,619 $280 Million
Q4 2019

Oct 02, 2024

BUY
$77.58 - $87.54 $4.75 Million - $5.36 Million
61,203 Added 1498.24%
65,288 $3.29 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cannon Financial Strategists, Inc. Portfolio

Follow Cannon Financial Strategists, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.